FORMULATE Trademark Information

Trademark by Formulate Bioscience, Inc.

Pharmaceutical preparations; human endocannabinoid system-based therapies; therapeutic agents for binding and activating encannabinoid receptors

Pharmaceutical research and development services; research and development services in the field of endocannabinoid systems; providing medical and scientific research information in the field of endocannabinoid systems and endocannabinoid system-based therapies

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
Class (042)
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: FORMULATE
Status/Status Date:
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
11/8/2021
Serial Number: 90318471
Filing Date: 11/13/2020
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Pharmaceutical preparations; human endocannabinoid system-based therapies; therapeutic agents for binding and activating encannabinoid receptors
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: N/A
Last Applicant/Owner:
Formulate Bioscience, Inc.
********
********
***** ****
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
********
********
***** ****
Current Status:
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
11/8/2021
Correspondent Search:
KAREN WON is a correspondent of FORMULATE trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on